Asia, with 8% from Europe, the Middle East, and Africa. 95% of the funds came from asset managers, while 5% were raised from ...

Piramal Pharma Ltd. expects new molecule development and an $80 million expansion of its sterile injectable facility in ...

Piramal Pharma Solutions, a contract development and manufacturing organisation, has announced an $80m investment to expand ...

On 9 September the US House of Representatives passed the draft of the Biosecure Act, which aims to prohibit US pharma ...

Arvind Iyer, Head of Marketing Piramal Finance, explains his marketing strategy being rooted in understanding customer ...

Piramal Capital & Housing Finance Limited (Piramal Finance), a wholly-owned subsidiary of Piramal Enterprises Ltd (PEL), to ...

Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635) has released its third independent annual Sustainability Report ...

Piramal Finance raises $150 million from international markets at 7.078% yield, attracting high-quality demand from global ...

Piramal Capital and Housing Finance raises USD 150 million through a global bond sale, achieving a better pricing than ...

From a geographical spread perspective, 92 per cent of the funds were raised from Asia, while the rest was from Europe, ...

In a separate regulatory filing, the company also said that it has raised $150 million through a global bond sale. The bonds ...